Ardent Health (NYSE:ARDT) Announces Quarterly Earnings Results, Misses Expectations By $0.06 EPS

Ardent Health (NYSE:ARDT) posted its earnings results on Tuesday, August 4th. The company reported $0.12 EPS for the quarter, missing analysts’ consensus estimates of $0.18 by ($0.06), FiscalAI reports. The company had revenue of $1.62 billion during the quarter, compared to the consensus estimate of $1.59 billion. Ardent Health had a return on equity of 10.35% and a net margin of 1.22%. Ardent Health updated its FY 2026 guidance to 0.780-1.150 EPS.

Ardent Health Stock Performance

Shares of ARDT opened at $10.88 on Tuesday. Ardent Health has a one year low of $7.71 and a one year high of $15.48. The company has a market cap of $1.53 billion, a PE ratio of 19.78, a P/E/G ratio of 3.09 and a beta of 0.71. The stock has a 50-day moving average of $10.72 and a 200-day moving average of $9.82. The company has a debt-to-equity ratio of 0.61, a current ratio of 2.10 and a quick ratio of 1.99.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently added to or reduced their stakes in the company. VARCOV Co. bought a new stake in shares of Ardent Health during the fourth quarter valued at approximately $232,000. Wells Fargo & Company MN raised its position in shares of Ardent Health by 29.1% during the fourth quarter. Wells Fargo & Company MN now owns 25,963 shares of the company’s stock worth $229,000 after purchasing an additional 5,858 shares during the period. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC bought a new position in shares of Ardent Health in the 4th quarter worth $228,000. WINTON GROUP Ltd bought a new position in shares of Ardent Health in the 2nd quarter worth $228,000. Finally, Alliancebernstein L.P. grew its position in Ardent Health by 24.8% in the 3rd quarter. Alliancebernstein L.P. now owns 16,472 shares of the company’s stock valued at $218,000 after purchasing an additional 3,272 shares during the period.

Wall Street Analyst Weigh In

Several brokerages have commented on ARDT. Royal Bank Of Canada lifted their target price on Ardent Health from $12.00 to $13.00 and gave the stock an “outperform” rating in a report on Monday, August 10th. Zacks Research lowered shares of Ardent Health from a “hold” rating to a “strong sell” rating in a report on Thursday, August 6th. Weiss Ratings downgraded shares of Ardent Health from a “sell (d+)” rating to a “sell (d)” rating in a research report on Tuesday, August 11th. The Goldman Sachs Group reaffirmed a “neutral” rating and issued a $13.00 price objective on shares of Ardent Health in a research note on Thursday, August 6th. Finally, Wall Street Zen cut shares of Ardent Health from a “buy” rating to a “hold” rating in a research report on Sunday, July 12th. Seven analysts have rated the stock with a Buy rating, four have given a Hold rating and three have given a Sell rating to the stock. According to MarketBeat, the company presently has an average rating of “Hold” and an average target price of $13.05.

About Ardent Health

Ardent Health, listed on the New York Stock Exchange under the ticker ARDT, is a healthcare delivery company focused on acquiring, developing and managing acute care hospitals and complementary outpatient facilities across the United States. The company’s integrated platform encompasses both inpatient and outpatient services, designed to provide end-to-end care solutions and address the full continuum of patient needs.

Through its network, Ardent Health operates general hospitals, emergency departments, ambulatory surgery centers, urgent care clinics, rehabilitation and post-acute care facilities.